2009-11-13 14:03:03 - Osiris Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/osiris-thera ..

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory Graft versus Host Disease (GvHD), Crohn´s disease and for the repair of gastrointestinal injury resulting from radiation exposure, and is the only stem cell therapeutic granted both Orphan Drug and Fast Track status by the United States Food and Drug Administration (FDA). Prochymal is also being developed for the repair of heart tissue following a heart attack, for protection of pancreatic islet cells in patients with type I diabetes, and

 

 

for the treatment of Chronic Obstructive Pulmonary Disease (COPD). More from Reuters »

Osiris Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Osiris Therapeutics, Inc. (Osiris) is a biotechnology company that commercializes stem cell therapeutic products taken from the adult bone marrow. The company is involved in development and sale of various products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. Osteocel, Chondrogen and Prochymal are some of the key products of the company. It has presence across United States and Japan. The company is headquartered in Columbia, the United States. Recently in March 2009, Osiris agreed to transfer its Osteocel business to NuVasive under the asset purchase and manufacturing agreement. In January 2009, the company received U.S.

The Osiris Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.